hepatic gluconeogenesis

Every compound in the sci-wiki that affects hepatic gluconeogenesis; the ones you can source are floated to the front, then the reference-only entries. Tap any for the full entry, mechanism, and outlets.

2 sourced · 0 reference

←hepatic gluconeogenesis2/2

Blend

Glimepiride + Metformin

Glimepiride and metformin is a fixed-dose combination medication used to treat type 2 diabetes mellitus, pairing two oral glucose-lowering drugs with complementary actions. Metformin is a biguanide that lowers blood sugar chiefly by reducing glucose production in the liver and improving insulin sensitivity, while glimepiride is a sulfonylurea that stimulates the pancreas to release more insulin. Combining them in a single tablet is intended to improve blood-sugar control and simplify treatment for people whose diabetes is not adequately managed by one agent alone.

1 outlet

Blend

Pioglitazone + Metformin

Pioglitazone plus metformin is a fixed-dose combination tablet that unites two oral diabetes medicines with complementary actions: pioglitazone, a thiazolidinedione that makes tissues more sensitive to insulin, and metformin, a biguanide that mainly reduces the amount of glucose released by the liver. It is used to improve blood sugar control in adults with type 2 diabetes whose condition is not adequately managed on metformin alone. Combining the two drugs in a single pill is intended to lower blood sugar more fully while simplifying treatment, and it is marketed under names such as ACTOplus Met and Competact.

1 outlet